Inactive Instrument
Quotes Human Genome Sciences
Stocks
US4449031081
Biotechnology & Medical Research
|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 12-07-26 | Actelion Ltd : Exclusive: Human Genome rejected Amgen's $7 billion bid in 2010: sources | RE |
| 12-07-16 | BioMarin Pharmaceutical Inc. : GSK clinches deal to buy Human Genome for $3 billion | RE |
Stock exchange
Nasdaq- $
-
0
$
| Markets | Price | Change | Volumes |
|---|
Basic data
Market Cap (USD)
0
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | 0 | |
| -0.84% | -1.60% | +1.30% | +18.31% | 50.47B | |
| -6.00% | -0.75% | +447.48% | +524.26% | 44.56B | |
| -0.24% | +0.74% | +37.18% | +16.57% | 43.08B | |
| -1.55% | -2.07% | +19.83% | +73.63% | 41.7B | |
| -0.31% | -0.83% | +19.47% | +48.24% | 33.21B | |
| -1.79% | -3.24% | +26.32% | +121.63% | 16.77B | |
| -0.58% | -2.12% | - | - | 16.28B | |
| -0.33% | -1.56% | +10.99% | +26.88% | 14.58B | |
| -1.66% | -1.25% | +78.49% | +39.02% | 13.92B | |
| Average | -1.48% | -1.39% | +80.13% | +108.57% | 27.46B | |
| Weighted average by Cap. | -1.69% | -1.21% | +95.92% | +126.39% |
Historical Quotes: Human Genome Sciences
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
- Stock Market
- Stocks
- Stock
- Quotes Human Genome Sciences
Select your edition
All financial news and data tailored to specific country editions
